tetano
Editor, Senior Moderator
Cureus
. 2022 Aug 23;14(8):e28309.
doi: 10.7759/cureus.28309. eCollection 2022 Aug.
A Systematic Review of Neurological Manifestations of COVID-19
Sumeru Thapa Magar[SUP] 1 [/SUP], Hatim I Lokhandwala[SUP] 2 [/SUP], Saima Batool[SUP] 3 [/SUP], Faiqa Zahoor[SUP] 4 [/SUP], Syeda Kisa Fatima Zaidi[SUP] 3 [/SUP], Saveeta Sahtiya[SUP] 2 [/SUP], Deepa Khemani[SUP] 5 [/SUP], Sumeet Kumar[SUP] 6 [/SUP], Diana Voloshyna[SUP] 7 [/SUP], Faraz Saleem[SUP] 8 [/SUP], Muhammad Abu Zar Ghaffari[SUP] 8 [/SUP]
Affiliations
Abstract
The coronavirus can infect the upper respiratory tract, sinuses, and nose, and its severity manifests in its respiratory symptoms and neurological and psychological consequences. The majority of people who have COVID-19 present with moderate flu-like illness, and patients who are elderly with comorbid conditions, such as hypertension and diabetes, are more prone to experience severe illness and death. However, in the ongoing COVID-19 pandemic, neurological consequences have become a substantial source of morbidity and mortality. COVID-19 poses a global hazard to the nervous system because of its widespread dispersion and multiple pathogenic pathways. This review offers a critical assessment of the acute and long-term neurological effects of the COVID-19 virus. Some neurological problems include headache, dizziness, myalgia/fatigue, meningitis, ischemic/hemorrhagic stroke, and myelitis. Other people who have contracted COVID-19 also exhibit neurological features such as loss of taste and smell, reduced consciousness, and Guillain-Barré syndrome. This study seeks to help neurologists comprehend the wide range of neurologic aspects of COVID-19, as understanding neurological symptoms may help with the management and enhance the patient's outcomes.
Keywords: central nervous system (cns); covid-19; neurological manifestations; peripheral nervous system (pns); sars-cov-2.
. 2022 Aug 23;14(8):e28309.
doi: 10.7759/cureus.28309. eCollection 2022 Aug.
A Systematic Review of Neurological Manifestations of COVID-19
Sumeru Thapa Magar[SUP] 1 [/SUP], Hatim I Lokhandwala[SUP] 2 [/SUP], Saima Batool[SUP] 3 [/SUP], Faiqa Zahoor[SUP] 4 [/SUP], Syeda Kisa Fatima Zaidi[SUP] 3 [/SUP], Saveeta Sahtiya[SUP] 2 [/SUP], Deepa Khemani[SUP] 5 [/SUP], Sumeet Kumar[SUP] 6 [/SUP], Diana Voloshyna[SUP] 7 [/SUP], Faraz Saleem[SUP] 8 [/SUP], Muhammad Abu Zar Ghaffari[SUP] 8 [/SUP]
Affiliations
- PMID: 36168382
- PMCID: PMC9506361
- DOI: 10.7759/cureus.28309
Abstract
The coronavirus can infect the upper respiratory tract, sinuses, and nose, and its severity manifests in its respiratory symptoms and neurological and psychological consequences. The majority of people who have COVID-19 present with moderate flu-like illness, and patients who are elderly with comorbid conditions, such as hypertension and diabetes, are more prone to experience severe illness and death. However, in the ongoing COVID-19 pandemic, neurological consequences have become a substantial source of morbidity and mortality. COVID-19 poses a global hazard to the nervous system because of its widespread dispersion and multiple pathogenic pathways. This review offers a critical assessment of the acute and long-term neurological effects of the COVID-19 virus. Some neurological problems include headache, dizziness, myalgia/fatigue, meningitis, ischemic/hemorrhagic stroke, and myelitis. Other people who have contracted COVID-19 also exhibit neurological features such as loss of taste and smell, reduced consciousness, and Guillain-Barré syndrome. This study seeks to help neurologists comprehend the wide range of neurologic aspects of COVID-19, as understanding neurological symptoms may help with the management and enhance the patient's outcomes.
Keywords: central nervous system (cns); covid-19; neurological manifestations; peripheral nervous system (pns); sars-cov-2.